Heavily indebted poor countries (HIPC) vs Sweden: Access to anti-retroviral drugs, male
Heavily indebted poor countries (HIPC)
80.4%
in 2024
Sweden
95.0%
in 2022
Heavily indebted poor countries (HIPC) rank
6th
Sweden rank
4th
Access to anti-retroviral drugs, male over time
- Heavily indebted poor countries (HIPC)
- Sweden
How they compare
Sweden currently reports 95.0% against 80.4% in Heavily indebted poor countries (HIPC), a difference of 14.6%.
That makes Sweden's figure about 1.2 times Heavily indebted poor countries (HIPC)'s.
Across all 23 years both countries report, Sweden has been ahead every year.
Heavily indebted poor countries (HIPC) ranks 6th and Sweden ranks 4th of 19 groups.
Sweden has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Heavily indebted poor countries (HIPC) | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.7% | 53.7% | 48.0% | Sweden |
| 2010s | 39.0% | 92.5% | 53.5% | Sweden |
| 2020s | 68.7% | 95.3% | 26.7% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Heavily indebted poor countries (HIPC) or Sweden?
- Sweden, at 95.0% against 80.4% in Heavily indebted poor countries (HIPC) as of 2022.
- What is the difference in access to anti-retroviral drugs, male between Heavily indebted poor countries (HIPC) and Sweden?
- 14.6%, with Sweden ahead.
- How many years of comparable data are there for Heavily indebted poor countries (HIPC) and Sweden?
- 23 years are reported by both, from 2000 to 2022.
- How do Heavily indebted poor countries (HIPC) and Sweden rank globally for access to anti-retroviral drugs, male?
- Heavily indebted poor countries (HIPC) ranks 6th and Sweden ranks 4th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.